Related Experiment Video
Updated: Jun 2, 2026
07:42
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Dual-task performance in Alzheimer's disease, mild cognitive impairment, and normal ageing
Jennifer A Foley1, Reiner Kaschel, Robert H Logie
1Human Cognitive Neuroscience, University of Edinburgh, Edinburgh, UK. jfoley@ed.ac.uk
Summary
Dual-tasking impairment is specific to Alzheimer's disease (AD), not mild cognitive impairment (MCI) or normal aging. A new assessment shows AD patients struggle with dual tasks, while MCI and healthy controls perform similarly.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Gerontology
Background:
- Dual-tasking, the ability to perform two tasks simultaneously, is often impaired in neurodegenerative conditions.
- The specific stage of cognitive decline where dual-tasking deficits emerge in Alzheimer's disease (AD) remains incompletely understood.
Purpose of the Study:
- To investigate if a novel paper-and-pencil dual-tasking assessment can differentiate between Alzheimer's disease (AD), mild cognitive impairment (MCI), and healthy aging.
- To determine the specificity of dual-tasking deficits to AD.
Main Methods:
- A cohort of 50 AD patients, 49 MCI patients, and 50 healthy controls completed a new paper-and-pencil dual-tasking assessment.
- Performance metrics were analyzed to compare dual-tasking ability across the three groups.
Main Results:
- The Alzheimer's disease (AD) group exhibited a statistically significant impairment in dual-task performance.
- No significant differences in dual-tasking ability were observed between the mild cognitive impairment (MCI) group and the healthy control group.
Conclusions:
- The findings indicate that significant dual-tasking impairment is a specific characteristic of Alzheimer's disease (AD).
- This deficit does not appear to be present in the early stages of cognitive decline (MCI) or normal aging, suggesting it may be a marker for AD progression.
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...